Skip to content

Legal status · United States

Is Argireline with Matrixyl and SNAP-8 legal in the United States?

Written by Reviewed Sep 2026

Not approvedCosmeticHuman studies cited: 1

Direct answer

Argireline with Matrixyl and SNAP-8 can be sold in the United States as a supplement or cosmetic ingredient, classified as "Permitted in cosmetics". That is not drug approval: FDA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.

Argireline with Matrixyl and SNAP-8 in the United States at a glance

ClassificationPermitted in cosmetics
NoteSold as cosmetics. No premarket approval; anti-wrinkle appearance claims are permitted, structural claims are not.
FDA approval statusCosmetic ingredients, not drugs. Cosmetic products are not subject to premarket approval in the United States, and claims that a product changes the structure or function of skin would make it a drug claim.
Human studies cited1 of 3 citations on the profile
ReviewedSep 2026

Classification and note come from the Argireline with Matrixyl and SNAP-8 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.

What this means

  • 01

    Argireline with Matrixyl and SNAP-8 can be sold in the United States as a supplement, food or cosmetic ingredient under the classification above, without drug approval.

  • 02

    Supplement status means FDA has not evaluated any health claim; manufacturers are responsible for safety and labeling, and quality varies by product.

  • 03

    Injectable or "research use only" versions are not supplements. That label does not make human use lawful, and injectables fall under medicines rules.

What Argireline with Matrixyl and SNAP-8 is

The standard three-peptide face serum. One component has a randomised placebo-controlled trial in 60 people; the other two have trade names rather than trials. The percentage on the bottle almost never describes the peptide, because these ingredients are sold to formulators as dilute supplier solutions, so a serum labelled with a peptide percentage usually contains a fraction of that in actual peptide.

This is the most widely sold blend in this database by unit volume and the one where the label is least likely to mean what a buyer thinks. Start with what has been tested.

Mechanism: Argireline is claimed to interfere with SNARE complex formation and catecholamine release, the topical analogue of what botulinum toxin does by injection, at a fraction of the potency. The palmitoyl peptides in the Matrixyl family are matrikines claimed to signal fibroblasts to produce collagen.

Regulatory history: Cosmetic ingredients, not drugs. Cosmetic products are not subject to premarket approval in the United States, and claims that a product changes the structure or function of skin would make it a drug claim.

How FDA treats this kind of product

Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.

The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Argireline with Matrixyl and SNAP-8 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Argireline with Matrixyl and SNAP-8 in other countries

Frequently asked questions

Is Argireline with Matrixyl and SNAP-8 legal in the United States?

Argireline with Matrixyl and SNAP-8 can be sold in the United States as a supplement or cosmetic ingredient, classified as "Permitted in cosmetics". That is not drug approval: FDA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: Sold as cosmetics. No premarket approval; anti-wrinkle appearance claims are permitted, structural claims are not.

Can I buy Argireline with Matrixyl and SNAP-8 in the United States?

Yes, in supplement or cosmetic form. In the United States Argireline with Matrixyl and SNAP-8 is classified as "Permitted in cosmetics", so oral, topical or cosmetic products can be sold under supplement rules. Injectable versions and products labeled "research use only" are not supplements and are not approved for human use. Note: Sold as cosmetics. No premarket approval; anti-wrinkle appearance claims are permitted, structural claims are not.

Is Argireline with Matrixyl and SNAP-8 FDA approved?

No. FDA status: Cosmetic ingredients, not drugs. Cosmetic products are not subject to premarket approval in the United States, and claims that a product changes the structure or function of skin would make it a drug claim.. Current US classification: "Permitted in cosmetics". On the evidence, 1 human study is cited on its profile.

Related compounds in the United States

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Argireline with Matrixyl and SNAP-8 live on its compound profile.

Argireline with Matrixyl and SNAP-8 profile

This page is general information about the regulatory status of Argireline with Matrixyl and SNAP-8 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.